8月13日 - ** 肿瘤药物开发商Zentalis Pharmaceuticals（ZNTL.O）因寻求融资，其股价在盘后交易中下跌约10%，至3.75美元
** ZNTL (link) 启动由股票和预先注资的认股权证组成的发行；交易规模未披露
** 该公司计划将募集资金净额用于资助临床试验、临床前研究、监管申报等用途
** 多伦多道明考恩（TD Cowen）、古根海姆（Guggenheim）和奥本海默（Oppenheimer）担任联合簿记管理人
** ZNTL股价周四收跌3.3%，报4.15美元，但年初至今涨幅已超过三倍
** 这家位于加利福尼亚州圣地亚哥的公司流通股约为7170万股，市值约为3亿美元
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.